Optimal viral strategies for bypassing RNA silencing by Rodrigo, Guillermo et al.
1	  
	  
Optimal viral strategies for bypassing RNA silencing 
 
Guillermo Rodrigo1, Javier Carrera1,2, Alfonso Jaramillo3,4, 
and Santiago F. Elena1,5,* 
 
1Instituto de Biología Molecular y Celular de Plantas, Consejo Superior de Investigaciones 
Cientíﬁcas-Universidad Politécnica de Valencia, Campus UPV CPI 8E, Ingeniero Fausto 
Elio s/n, 46022 Valencia, Spain 
2ITACA, Universidad Politécnica de Valencia, Camino de Vera s/n, 46022 Valencia, Spain 
3École Polytechnique, Route de Saclay, 91128 Palaiseau Cedex, France 
4Epigenomics Project, Genopole-Université d’Évry Val d’Essonne-CNRS UPS3201, 
Batiment Geneavenir 6, 5 Rue Henri Desbruères, 91030 Évry Cedex, France 
5Santa Fe Institute, 1399 Hyde Park Road, Santa Fe, NM 87501, USA 
 
*Author and address for correspondence: IBMCP, CSIC-UPV, Campus UPV CPI 8E, 
Ingeniero Fausto Elio s/n, 46022 València, Spain (sfelena@ibmcp.upv.es) 
2	  
	  
The RNA silencing pathway constitutes a defense mechanism highly conserved in 
eukaryotes, especially in plants, where the underlying working principle relies on the 
repressive action triggered by the intracellular presence of double-stranded RNAs.  This 
immune system performs a post-transcriptional suppression of aberrant mRNAs or viral 
RNAs by small interfering RNAs that are directed towards their target in a sequence-
specific manner.  However, viruses have evolved strategies to escape from silencing 
surveillance while promoting their own replication.  Several viruses encode suppressor 
proteins that interact with different elements of the RNA silencing pathway and block it.  
The different suppressors are not phylogenetically nor structurally related and also differ in 
their mechanism of action.  Here, we adopt a model-driven forward-engineering approach 
to understand the evolution of suppressor proteins and, in particular, why viral suppressors 
preferentially target some components of the silencing pathway.  We analyzed three 
strategies characterized by different design principles: replication in the absence of a 
suppressor, suppressors targeting the first protein component of the pathway and 
suppressors targeting the small interfering RNAs.  Our results seed light into the question 
of whether a virus must opt for devoting more time into transcription or into translation and 
on which would be the optimal step of the silencing pathway to be targeted by suppressors.  
In addition, we discussed the evolutionary implications of such designing principles. 
 
Keywords: RNA silencing; silencing suppression; systems and synthetic biology; 
transcription-translation tradeoff; virus evolution; virus-host interaction 
Running title: Virus suppression of RNA silencing 
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1.  INTRODUCTION 
RNA viruses are diﬃcult to control and eliminate because of their rapid evolution.  This 
high evolvability is a consequence of their high mutation rates, large population size and 
short generation times (Domingo & Holland 1997; Elena & Sanjuán 2007) that confer them 
an astonishing ability to explore genotypic space.  Indeed, RNA viruses typically have 
mutation rates orders of magnitude higher than their DNA hosts (Drake & Holland 1999).  
Eukaryotic organisms have developed a sequence-specific mechanism to modulate gene 
expression based on RNA interference (RNAi) which was first found in the nematode 
Caenorhabditis elegans (Fire et al. 1998) and later on in many other eukaryotes including 
plants (Vaucheret et al. 2001) and mammals (Elbashir el al. 2001).  Likewise, this 
molecular mechanism is able to silence viral or aberrant genes. 
The underlying working principle of RNA silencing relies on the repressive action 
triggered by the intracellular presence of double-stranded RNAs (dsRNA) (Fire et al. 
1998).  In the case of single-stranded RNA viruses (ssRNA), dsRNAs are byproducts of 
genome replication mediated by virus-encoded RNA-dependent RNA polymerases (RdRp).  
During viral genome replication, the dsRNA intermediates become the target of the first 
component of the silencing pathway, DICER, a type-III RNase that degrades these dsRNA 
into units of 21 to 24 nucleotides called small interfering RNAs (siRNA) (Hamilton & 
Baulcombe 1999).  Subsequently, the cellular RNA-induced silencing complex (RISC), that 
contains the argonaute (AGO) endonuclease (Bohmert et al. 1998), loads the antisense 
siRNAs resulting in an active form.  Using the antisense siRNA as a guide, AGO cleaves 
the target viral ssRNA (Rand et al. 2005).  Furthermore, in a secondary cycle of 
ampliﬁcation, the host’s RNA-dependent RNA polymerase VI (RDR6) uses siRNAs as 
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primers, together with partially degraded ssRNAs, to produce long dsRNAs that serve as 
new substrates for DICER, a process known as transitivity (Voinnet et al. 1998).  siRNAs 
systemically move from cell-to-cell immunizing new cells against infection (Voinnet et al. 
1998; Himber et al. 2003).  Given the properties of the RNA silencing pathway (specificity 
and amplification), it represents a sort of innate immune system for plants (Lecellier & 
Voinnet 2004; Ding & Voinnet 2007). 
Not surprisingly, viruses have evolved strategies to actively evade the RNA silencing 
surveillance while promoting their own replication (Li & Ding 2006).  Many viruses 
encode a suppressor protein (viral suppressor of RNA silencing or VSR) that interacts with 
elements of the silencing pathway blocking it (Brigneti et al. 1998; Kasschau & Carrington 
1998; Baulcombe 2002).  The targets of these VSRs within the RNA silencing pathway are 
diverse: DICER, the dsRNA, the siRNA, RISC, or the systemic signal (Moissiard & 
Voinnet 2004; Li & Ding 2006; Díaz-Pendón & Ding 2008).  For example, the helper 
component-protease (HC-Pro) encoded by the Potyvirus works as suppressor by 
sequestering siRNAs (Mallory et al. 2002; Chapman et al. 2004; Dunoyer et al. 2004; 
Lakatos et al. 2004).  This binding prevents the incorporation of siRNAs into RISC.  
Furthermore, by also binding plant endogenous micro-RNAs (miRNA) and controlling the 
expression of other genes, HC-Pro may interfere the expression of DICER proteins (Deleris 
et al. 2006), reducing the degradation of dsRNAs and, thus, favoring potyvirus replication.  
Similarly, the Nodavirus B2 suppressor also sequesters siRNAs (Li & Ding 2002).  The 
Tombusviridae P19 and Cucumovirus 2b suppressors interfere with the systemic spread of 
the 24 nucleotides siRNAs produced by DCL3 (Qi et al. 2004).  Some suppressors act on 
RISC, either avoiding the upload of siRNAs into AGO, like the Closterovirus P21 
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(Peremyslov et al. 1998), by binding to AGO1 and avoiding its interaction with other 
proteins required to assemble the RICS, as the coat protein (CP) of Tombusvirus (Azevedo 
et al. 2010), by inhibiting the RISC activity after its maturation, like the Begomovirus AC4 
(Vanitharami et al. 2004), or by targeting AGO for degradation, as it is the case for 
Polerovirus P0 protein (Baumberger et al. 2007; Csorba et al. 2010).  It has also been 
recently shown that V2 suppressor of Geminivirus competes with SGS3, a key component 
of the secondary cycle of siRNAs amplification, in binding dsRNAs and thus interferes 
with transitivity (Fukunaga & Doudna 2009).  Finally, the CP of some carmoviruses (Meng 
et al. 2006) and the P14 of Aureusvirus (Mérai et al. 2005) can also bind long dsRNAs, 
resulting in the protection of the intermediaries of replication from DICER activity.  
Accordingly, VSRs have been divided into three families (Díaz-Pendón & Ding 2008): (i) 
those enhancing within cell virus accumulation, (ii) those essential for cell-to-cell 
movement but dispensable on virus accumulation in single cells, and (iii) those that 
facilitate virus long-distance movement and/or intensify disease symptoms but are not 
essential for viral replication and cell-to-cell movement. 
The first mathematical models of the RNA silencing pathway focused on aberrant 
cellular mRNA as triggers of the silencing response (Bergstrom et al. 2003; Groenenboom 
et al., 2005).  More recent models consider viral RNAs as triggers of the response and 
focused in virus’ spread in the plant (Groenenboom & Hogeweg 2008a; Groenenboom & 
Hogeweg 2008b).  However, on the one hand, these studies did not analyze in detail the 
possible effect that different viral suppressor strategies may have in the outcome of the 
interaction.  On the other hand, although many several kinetic models of intracellular 
growth have been proposed for different viruses, none of them specifically incorporates the 
6	  
	  
silencing response (e.g., Reddy & Yin 1999; Sidorenko & Reichl 2004; Lim et al. 2006; 
Dahari et al. 2007; Sardanyés et al. 2009).  In this work, we present the first model that 
incorporates the interaction of different suppressor proteins with components of the 
silencing pathway.  We perform a dynamical analysis and show the time course of viral 
RNA accumulation under a wide set of parameter states.  We also show phase diagrams for 
different combinations of parameters and focus our discussion in the behavior of the system 
for different viral replication and translation rates in the presence/absence of different 
suppressor strategies.  These analyses allow us to rationalize why different viruses may opt 
for different strategies in their investment into producing new genomes (i.e., transcription 
via antigenomic strains) or into producing large amounts of protein from a few initial sense 
genomes (i.e., translation).  Such models are important to unveil defense strategies and 
design principles of viral systems. 
 
2.  THE MODEL 
We have constructed a mathematical model based on nonlinear differential equations to 
describe the interplay between the silencing pathway and a positive-sense RNA virus that 
encodes for a single polyprotein that is processed into mature peptides, as it is the case for 
picorna-like viruses (e.g., poliovirus, hepatitis C virus, foot-and-mouth disease virus and 
the potyviruses, which are the largest and more important family of plant viruses).  The 
model involves the following molecular species: genomic and antigenomic ssRNA (S+ and 
S−, respectively), dsRNA (D), antisense siRNA (I), viral proteins (P), virions (V), primed 
ssRNA (S*), and secondary dsRNA (D*).  Three different viral proteins are considered, the 
nonstructural replicase and VSR and the structural CP.  Their corresponding relative 
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abundances are p, q and 1 − p − q respectively.  This constraint is biologically relevant for 
picornaviruses as all proteins are self-processed from a single polyprotein and, thus, their 
relative abundances remain constant during infection.  In addition, the model accounts for 
several cellular components: the ribosomes (Z), the RDR6 polymerase involved in 
transitivity (Y), DICER-like proteins (C), and inactivated and activated RISC (R and R*, 
respectively).  We assume that at the beginning of infection, a single viral ssRNA genome 
is present, which in our particular model must be genomic.  Notice that genomic strands are 
those that encode for proteins whereas antigenomic strands are the complementary and, for 
simplification, we will assume are not coding.  To accommodate negative sense RNA 
viruses, the model can be straightforwardly modified (in this case the negative strand is 
encapisdated and cleaved by RISC) and changing the initial conditions.  For retroviruses or 
DNA viruses, the model must be conveniently modified. 
The model is constructed following a generalized enzyme kinetics scheme where both 
substrates and enzymes are limited in the medium (DeAngelis et al. 1975), and there are 
competitions between different enzymes for the same substrate and different substrates for 
the same enzyme (MacRae et al. 2007).  This gives a highly coupled formulation.  In Fig. 1 
we show the scheme of RNA silencing pathway, and the kinetic parameters are shown in 
Table 1, with parameter values taken from different sources. 
Viral replication is a process involving multiple reactions aiming to bypass the 
defense systems of the cell.  The RNA replication rates (J), for both polarities, are given by 
the following set of equations: 
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where α is the maximum replication rate per molecule of ssRNA, KP, KR, KZ, and KC are 
the binding constants for the replicase, the activated RISC, the ribosomes and the CP, 
respectively.  The affinity of the replicase for the antigenomic strands is incorporated into 
the model by the parameter ω.  If ω = 1, then the RdRp has the same affinity for both 
strains, whereas ω > 1 would imply a lager affinity for the antigenomic strain.  By doing so, 
we can model replication modes ranging from the geometric (ω = 1) to the stamping 
machine one (ω >> 1) (Sardanyés et al. 2009). 
A molecule of dsRNA can be separated into two ssRNA molecules of complementary 
polarity at a first-order rate with constant parameter β 
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In addition, genomic ssRNAs are translated into viral proteins with rate 
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where µ is the maximum translation rate per molecule of genomic ssRNA. 
The process of RNA silencing is initiated when DICER cleaves dsRNA into siRNAs.  
The rates describing this process are given by the following set of equations: 
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where δ and KD are the catalytic and binding constants of DICER, respectively.  
Afterwards, RISC is activated by uploading the antisense siRNAs produced by DICER into 
AGO according to the equation 
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where ρ and KI are the catalytic and binding constants of RISC, respectively.  Following 
the activation of RISC, it is now able of directing the cleavage of the viral ssRNA with rate 
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where υ is the catalytic constant of RNA cleavage.  CPs are pre-assembled with ssRNA to 
produce immature virions at a rate given by 
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where λ is the maximum assembly rate and k0 < k is the number of CP monomers 
associated to the immature virions, Vimmature.  Then, virions are produced at rate 
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where  γ is the maximum rate to produce virions, and k is the number of CPs necessary to 
complete a mature virion.  All species are thermodynamically degraded at rates κS 
(ssRNAs), κD (dsRNAs), κI (siRNAs), and κP (the rest of proteins or protein complexes). 
The effect exerted by different VSRs on DICER, RISC and RDR6 can be 
conveniently modeled by the following three equations, respectively: 
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where C0, and R0 and Y0 are the corresponding amounts of each protein in the cell, which 
are assumed to be in large excess, and ΓC, ΓR and ΓY are the binding coefficients of the 
corresponding VSR to their substrate protein, DICER, RISC, and RDR6, respectively.  The 
parameter f determines the efficiency at which the suppressor precludes the activity of its 
target.  For example, in the equation of DICER, an f = 0.01 means that even at saturating 
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concentration of the suppressor, 1% of DICER molecules will still be active.  To account 
for the suppression on siRNA, we modify JRISC and introduce a new equation to model the 
sequestration of siRNAs. 
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ρRI
KI
1+ I + RKI
+
qP
ΓI
,
Jsuppression =
ψqPI
ΓI
1+ I + qPKI
+
R
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,
  (2.10) 
	  
where ρ, ψ are, respectively, the rates at which RISC and the suppressor attach to the 
siRNA and ΓI the binding affinity of the suppressor for the siRNAs. 
After defining all the relevant rate equation, it is now possible to write a system of 
coupled differential equations describing the dynamics of the system: 
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* − Jreplication+ − Jcleavage+ − Jencapsidation −κSS+,
dS−
dt = Jdissociation − Jreplication
− −κSS−,
dP
dt = Jtranslation −κPP,
dD
dt = Jreplication
+ + Jreplication− − JDICER − Jdissociation −κDD,
dI
dt = nJDICER + n
*JDICER* − JRISC − Jsuppression −κ I I,
dR*
dt = JRISC − Jcleavage
+ −κPR*,
dS*
dt =σJcleavage
+ − Jreplication* − Jcleavage* −κSS*,
dD*
dt = Jreplication
* − JDICER* − Jdissociation* −κDD*,
dVimmature
dt = Jencapsidation − Jvirion −κPVimmature,
dV
dt = Jvirion −κPV ,
 (2.11) 
 
where the stoichiometric parameters n, n*, and σ represent, respectively, the number of 
siRNAs produced per molecule of dsRNA, the number of siRNAs produced in the 
secondary cycle of amplification, and the relative contribution of the secondary siRNA 
amplification to the degradation of dsRNA relative to the primary siRNAs. 
The full model in MATLAB format is available as electronic supplementary material. 
 
3.  STABILITY ANALYSIS 
The system (2.11) can be rewritten in a vectorial form as dy/dt = F(y) = ΩJ(y) − Ξy, where 
Ω  is the matrix of stoichiometric coefficients, J(y) the vector of production rates, and Ξ  a 
diagonal matrix with the vector of degradation rates.  The initial condition for the molecular 
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species involved in the system (y0) depends on the nature of the virus (i.e., the infectious 
particle containing a genomic or an antigenomic RNA strand).  Here we have considered 
for our analyses viruses encapsidating genomic RNAs and therefore all the elements in y0 
are zero except for S+ = 1.  In case of negative sense RNA viruses, the initial condition 
would be S− = 1.  Accordingly, we construct an initial value problem to obtain the dynamics 
of the system.  The vector of steady states is given by F(y∞) = 0, which serves to calculate 
the asymptotic behavior of the system through the eigenvalues of its Jacobian matrix 
∇F(y∞).  The behavior can change significantly by modifying pivotal parameters of the 
system.  Thus, the construction of bifurcation diagrams is a useful tool for evaluating the 
behavior regimes under different conditions, and also to build up a sensitivity analysis of 
the parameters of the system. 
We show that the trivial solution of the system (i.e., silenced virus) is stable.  The 
Jacobian matrix evaluated at y∞ = 0 is given by 
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where α’ = αY/KP, δ’ = δC0/KD, ρ’ = ρR0/KI, µ’ = µZ/KZ, α’’ = α’ + κS, δ’’ = δ’ + β + κD, 
and ρ’’ = ρ’ + κI.  This Jacobian has five negative real eigenvalues (−α’’, −ρ’’, −δ’’, −κS, 
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and −κP) that represent an asymptotically stable solution of the system.  Three of them have 
multiplicity greater than one.  The system also has a second non-trivial solution in which 
the virus beats the silencing response and replicates and accumulates in the cell.  Although 
we have verified numerically the existence of this non-trivial solution on the full model, 
without lost of generality, the stability analysis for this second solution can be done 
analytically by simplifying the system (2.11) as 
  
€ 
dS
dt = 2βD−αS
2 −υR*S −κSS,
dD
dt =αS
2 −δD−βD,
dR*
dt = nδD−υR
*S −κPR*,
 (3.2) 
 
where the non-trivial steady state is the solution of   
€ 
S β −δ( ) β + δ( ) =κS + nδαυS2 β + δ( ) υS +κP( ) .  The characteristic polynomial 
is  
€ 
−X 3 + τX 2 −ηX −Δ , where 
€ 
τ = −2αS −υR −κS −β −δ −υS −κP 	   is the trace of the 
Jacobian matrix, 
€ 
η = 2αS +υR +κS( ) β + δ +υS +κP( ) + υS +κP( ) β + δ( ) − 4αβS −υ 2RS 	   is 
the trace of its adjoint matrix, and 
€ 
Δ = 4αβS − 2αS +υR +κS( ) β + δ( )[ ] υS +κP( ) − 2nαδυS2 +υ 2RS β + δ( )  its determinant.  By 
applying the Routh-Hurwitz stability criterion, the system will be stable when τ < 0, Δ < 0 
and ητ < Δ.  Henceforth, by taking the appropriate kinetic parameters that meet these three 
conditions, the system is characterized by bistability and, therefore, the initial condition is 
pivotal to determine the outcome of the process. 
 
4.  RESULTS 
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4.1.  Virus replication in the absence of a VSR 
We have studied the viral replication dynamics by using the mathematical model presented 
in the previous section.  First, we considered the case of RNA viruses that do not encode 
suppressor proteins.  In Fig. 2 we show several time course evolutions of the system species 
(S+, S− and P) for two different sets of initial conditions.  When the multiplicity of infection 
is low (one single viral S+ genome per cell) and for the typical parameter values shown in 
Table 1, we show that the population is extinguished (Fig. 2a), after a transient where the 
concentration of P reaches a maximum.  The model predicts that in this situation, the 
amount of antigenomic strains S– produced is meaningless and its dynamics is dominated 
by the degradation term in the system of equations 2.11. 
However, the virus can bypass the silencing mechanism if the multiplicity of 
infection just increases to S+ = 10 molecules (Fig. 2b).  In this case, after a latency period of 
about 1 day, viral proteins reach a critical concentration and promote further exponential 
replication.  Analytically, the latency period can be estimated when P reaches ωKP.  In all 
these simulations the condition S+ > S− holds, in excellent agreement with the observation 
of an excess of sense siRNAs for positive-sense viral genomes (Qi et al. 2010).  The effect 
of further increasing the multiplicity of infection is to reduce the latency period (data not 
shown). 
We performed several sensitivity analyses to study the regions in parameter space in 
which viral replication occurs (non-trivial solution) or for which viral silencing takes place 
(trivial solution).  We found that the higher the affinity for the negative strand (lower ω), 
the wider is the parameter space for viral replication (Fig. 3a).  In fact, this can be 
rationalized because viral RdRps compete with ribosomes and with the activated RISC for 
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genomic strands, whereas they do not compete for antigenomic strands.  In addition, high 
replication rates also allow the virus to escape from the silencing machinery and to 
minimize the effect of non-specific thermodynamic degradation (Fig. 3b). 
One question that arises here is whether a tradeoff between replication and translation 
exists.  Upon uncoating and the strictly necessary first event of translation, a viral genome 
can either be directed to transcription, and thus increase the concentration of RNA, or to 
translation, and thus increase the concentration of viral proteins (in this case only replicase 
and coat).  In Fig. 3c we analyzed such tradeoff by considering the binding affinities to 
positive strands of replicase (KP) and ribosomes (KZ).  We showed that in the absence of a 
silencing suppressor, silencing is the outcome favored when translation is more frequent 
than transcription (KP < KZ).  Accordingly, the best strategy for a virus to bypass the RNA 
silencing response in the absence of a suppressor protein would be to increase the affinity 
of its RNA to the replicase rather than to optimize its binding affinity to the ribosomes.  
Likewise, by increasing its transcription efficiency, a virus will produce more copies of its 
genome up to the point in which the cleavage by DICER would no longer control the 
accumulation of viral genomes.  Fig. 3d shows, as expected, that the higher are the catalytic 
constants for transcription and translation, the higher are the chances for a successful viral 
replication. 	  
4.2.  Virus replication dynamics in presence of a VSR that acts on DICER 
Many, if not all, viruses encode proteins able of interacting with the cell molecular 
machinery.  The suppression mechanism is often a protein-protein or RNA-protein 
interaction resulting in a sequestration or blockage of one of the many molecules involved 
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in the silencing pathway that allows the virus to escape from silencing surveillance.  Our 
general model can be used to analyze and study the effect of various suppressors encoded 
by different viruses.  To analyze the effect of a suppressor, we considered the virus 
replication speed as a characteristic scoring function.  This speed can be easily computed as 
the inverse of the time taken to produce mature virions (TV).  In Fig. 4 we plot 1/TV versus 
KZ and KP for the case of a VSR operating over DICER.  We found that such a suppressor 
enhances the speed of virus accumulation with respect to a virus without encoding a VSR. 
To further analyze the suppressor strategy of manipulating DICER, we constructed a 
phase diagram between the catalytic constant of cleavage by DICER (δ) and the suppressor 
binding constant (ΓC) (Fig. 5a).  We found that the effect of the suppressor is only 
significant beyond a threshold level of ΓC (in this case 7000 molecules).  In other words, if 
the affinity of the suppressor is not high enough, it only represents a cost for the virus 
because it cannot help for its replication.  Fig. 5b shows the effect that the binding affinity 
of the suppressor for DICER has on the time necessary for completing a virion as a 
function of the cellular amounts of DICER (C0).  For low amounts of DICER, TV is 
insensitive to variation in ΓC.  In addition, an increase in the number of DICER molecules 
per cell does not have any effect on TV for suppressors with weak affinity.  However, if ΓC 
increases (moving rightwards in the ordinates axis in Fig. 5b), then the time to produce 
virions significantly grows up and becomes infinity (indicating viral silencing) for high 
amounts of DICER molecules present in the cell at the time of infection. 	  
4.3.  The effect of suppressing downstream steps of the silencing pathway 
Next, we sought for the effect of VSRs operating downstream in the silencing pathway.  
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Surprisingly, we found that suppressors affecting at other levels of the pathway (e.g. 
sequestering siRNAs, interfering with RISC or with RDR6) did not enlarge the parameter 
space in which the virus successfully replicates within a single cell (data not shown).  This 
result suggests that only by suppressing DICER, the first bottleneck to replication imposed 
by the system, viruses could widen the parameter region resulting in successful replication.  
Hence, the question is why do other types of VSRs, such as siRNA sequesters, have 
evolved?  Our negative result suggests that the RNA silencing mode of action cannot be 
rationalized by only looking into a single cell but that a more complex situation in which 
cell-to-cell effects may contribute should be considered.  This leads us to consider the role 
of the space to analyze such mechanism. 
In Fig. 6a we plot the relative amount of accumulated siRNA (normalized by the 
amount or siRNA produced in the absence of a viral suppressor of silencing, I/IΓ→∞ in 
presence of two suppressors strategies.  For illustrative purposes, we have chosen the 
successful operation over DICER described in the previous section and one based on 
sequestering siRNAs.  By increasing the affinity for the corresponding target molecule 
(moving rightwards on the ordinates axis) to the maximum value analyzed, the strategy 
based on blocking DICER reduces the concentration of siRNA around two orders of 
magnitude.  However, the strategy based on sequestering siRNAs is far less efficient since 
at the strongest affinity it only reduces the accumulation of virus-derived siRNAs by one 
order of magnitude. 
However, the transfer of siRNAs from infected to neighboring healthy cells, which 
allows the peripheral cells to activate RISC in the absence of viral infection, has the 
expected effect (Fig. 6b).  In the absence of triggering siRNAs, infection progresses with 
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the time delay already described above.  However, if the cell has been already activated, the 
virus is not able of overcoming the cleavage by RISC and runs into extinction. 
 
5.  DISCUSSION 
We have presented a deterministic model of the interplay between viral replication and the 
RNA silencing pathway.  For the sake of biological realism, we modeled a particular type 
of viruses, the picorna-like.  By doing so, the model pays the cost of reduced generality and 
the conclusions may not be applicable to viruses with other genomic architectures such as 
negative sense RNA, retroviruses or DNA viruses.  Although our results have been 
performed for positive sense RNA viruses, the model can also be used to study negative 
sense viruses with minor changes in some rates and the initial conditions.  Readers 
interested in exploring the interplay between the silencing pathway and any of these viruses 
must necessarily look this article as the starting point for developing their own models.  
Nonetheless, our approximation has allowed us to study and compare different viral 
suppression strategies.  We have shown that the RNA silencing pathway allows a large 
variety of behaviors, suggesting multiple potential evolutionary trajectories for RNA 
viruses.  Future models will account for different viral genomic organizations and for 
inherent stochastic effects associated to small numbers of molecules (Gillespie 1977).  The 
model here presented differs from other models of the interaction between virus and hosts 
silencing response (Groenenboom & Hogeweg 2008a; Groenenboom & Hogeweg 2008b) 
in which here we have explored the role played by different suppressors of RNA silencing.  
We have demonstrated and shown in Fig. 2 that the system has two stable steady states 
(replication and silencing) and, thus, the initial condition of the system (i.e., the initial 
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amount of ssRNA in the cell) is important to determine its dynamics.  Likewise, the higher 
is the initial amount of the viral RNA, the higher is the zone for exponential viral 
replication in the parameter space.  This suggests that increasing the multiplicity of 
infection is a possible strategy for virus to escape from the control of RNA silencing. 
We have shown that in the presence of an active silencing response, it is in the benefit 
of the virus to invest into a transcriptional strategy rather than in translation.  This may be 
somehow counterintuitive because one may expect more replication to generate more 
dsRNA and, therefore, to strength the silencing response and, likewise, more translation to 
produce more suppressor protein.  It can be argued that, after the very initial burst of 
translation from the infecting genomic sequence resulting in a few viral proteins, the 
optimal strategy involves synthesizing antigenomic strands and use them as templates for 
producing a large excess of genomic strands (i.e., using an stamping machine replication 
strategy) without diverting them into translation.  If replication is fast enough, this 
replicative strategy works even in the absence of a suppressor protein: a positive feedback 
is established such as the replication overcomes the capacity of the available DICER 
molecules to keep virus replication under control.  Once a significant amount of genomic 
strands has been produced, then translation may take place.  If translation results in a VSR 
protein, then a synergistic effect between fast transcription and translation appears, 
resulting in a successful viral replication. 
Among many possibilities, we have focused in three viral strategies.  The first one, 
consisting of blocking DICER, turns out to be the most efficient promoting viral 
replication.  This result is somehow logical from an optimal design perspective.  By hitting 
the first bottleneck in the pathway the virus ensures its own replication.  Hitting 
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downstream steps would allow DICER to still exert partial control on virus replication.  
The other three strategies explored, sequestering siRNA, blocking RISC and disrupting the 
secondary amplification via RDR6, have resulted less efficient in promoting intracellular 
virus accumulation, although they may gain some benefit when looking at cell-to-cell 
movement.  This finding is in good agreement with the observation that cucumovirus 2b 
and tombusvirus P19, which promote systemic and cell-to-cell movements, are not required 
for intracellular accumulation (Li & Ding 2006). 
Although mathematically convenient, it may be a biological oversimplification to 
assume that suppressors act at a single stage of the silencing pathway.  Evidences exist 
showing that VSRs may well simultaneously operate at diverse stages of the pathway.  For 
example, the potyviral HC-Pro sequesters siRNAs but also affects the expression of plant 
genes, including the dcl-like genes encoding for the different DICER proteins in 
Arabidopsis thaliana (Deleris et al. 2006), or by reducing the 3’ methylation of siRNAs 
making them sensitive to oligouridilation and subsequent degradation (Ebhardt et al. 2005; 
Mérai et al. 2006).  Another example of multiple actions is the polerovirus P0 that 
interferes with the silencing pathway at least at two levels: binding siRNAs and avoiding 
the formation of the activated AGO complex and labeling it for degradation (Baumberger et 
al. 2007; Csorba et al. 2010).  Also, a virus may also carry more than one VSR, as it seems 
to be the case for some tombusviruses (P19 and CP). 
We have also found that in certain regions of parameter space, a virus would be able 
of replicating even in the absence of a VSR.  The plant subviral pathogens known as viroids 
do not encode for any protein at all and are still able of replication in susceptible hosts 
(Daròs et al. 2006), despite the fact that their RNA molecules are targets of DICER (Di 
23	  
	  
Serio et al. 2009).  It has been suggested that viroids may evade silencing because their 
highly complex and packed secondary structure (Wang et al. 2004; Gómez & Pallás 2007).  
Other strategies viruses may use for avoiding silencing consist in replicating within 
spherules in the endoplasmic reticulum membrane (Schwartz et al., 2002), where they 
remain inaccessible to DICER. 
Although we have modeled the effect of VSRs on DICER as a direct protein-protein 
interaction, VSRs can also interfere with DICER activity by protecting the dsRNA as it is 
produced.  This particular activity would be easily incorporated into our mathematical 
framework in two simple ways.  First, by treating the binding affinity of DICER for dsRNA 
(KD) as a decreasing function of CP concentration.  Second, by defining a new molecular 
species for the complex dsRNA/CP and writing down the corresponding rates and adding a 
new differential equation in (2.11). 
In conclusion, we have shown that from a system design perspective, the best strategy 
that a virus may take to ensure its replication in presence of the antiviral response mediate 
by RNA silencing would be to (i) replicate fast and by producing an excess of genomic 
strands, (ii) encode for a VSR that interacts with the DICER protein and (iii) exert some 
control on the multiplicity of infection, ensuring that multiple genomes infect each cell.  
Obviously evolution is not a perfect designer and viruses have acquired suppressor proteins 
that target at different steps of the silencing pathway.  Understanding the exact mechanisms 
by which these VSRs operate will allow to develop better models and to increase our ability 
to predict the outcome of the virus-host interaction.  Furthermore, VSRs have clear 
biotechnological potential as they can be used to maximize the expression of transgenes (Li 
& Ding 2006).  Designing optimal suppressors would benefit from the knowledge advanced 
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in this article. 	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Figure 1.  Schematic representation of the RNA silencing pathway and its interaction with 
viral replication.  RNA viruses encode for replicase, suppressors of silencing (VSR) and 
coat proteins.  Three types of suppressors are considered in the scheme: suppressors of 
DICER (I), sequesters of siRNA (II), and suppressors of RISC (III). 	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Figure 2.  Dynamics of viral infection for diﬀerent initial conditions.  In (a) the starting 
condition of the simulation is a single viral genome; this results in the virus being silenced.  
In (b) the starting condition is that 10 viral genomes infect the cell; this high multiplicity of 
infection results in exponential viral replication after a period of latency of 1 day required 
to reach a threshold level of RdRp.  This successful infection happens even in the absence 
of a VSR.  The parameters values are those shown in Table 1. 	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Figure 3.  Phase diagrams identify different viral strategies.  Diagram (a) illustrates the 
effect of the catalytic constant of DICER cleavage (δ) in the replication rate (α) and the 
differential affinity of RdRp for positive and negative strands (ω).  Diagram (b) illustrates 
the relationship between α and the ssRNA degradation rate (κS), for different values of the 
translation rate (µ).  Diagram (c) shows the sensitivity of the binding constants of 
ribosomes (KZ) and replicases (KP) to α.  Diagram (d) illustrates the effect of KP on µ and 
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α.  Rep means viral replication bypassing silencing, and Sil viral extinction by silencing. 
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Figure 4.  Virus replication speed (computed as the inverse of the time to form a mature 
virion, TV) versus the binding constants of ribosomes (KZ) and replicases (KP), with ΓC = 
102 molecules.  (a) Virus without a VSR.  (b) Virus encoding a suppressor that blocks 
DICER.  The benefit associated with carrying such a suppressor is evaluated as the 
difference between both surfaces and is indicated by the dashed line and the arrow.  The 
other parameters take the values shown in Table 1.	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Figure 5.  (a) Phase diagram to analyze the suppressor effect on DICER between δ and ΓC, 
with α = 20 h−1 for different values of µ.  (b) Time to form one virion (TV) versus the 
suppressor constant of DICER, with α =µ = 20 h−1 for different values of C0 (in molecules).  
The other parameters take the values shown in Table 1.  Rep means viral replication 
bypassing silencing, and Sil viral extinction by silencing. 
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Figure 6.  (a) Amount of siRNA (relative to the amount accumulated without a viral 
suppressor of RNA silencing) versus the suppressor constant (Γ) on DICER or siRNA.  (b) 
Viral RNA dynamics in a cell which has not been immunized by receiving siRNA from 
neighboring cells (R*(0) = 0) and in a cell that has received a small input of siRNA from an 
infected neighbor cell (R*(0) = 10 molecules).  The parameters take the values shown in 
Table 1, expect α = 50 h−1. 
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Table 1.  Values for the kinetic parameters used in the model.  Other non-kinetic model 
parameters are p = q = 0.4, ω = 0.1, n = 2n* = 10, f = 0.01, σ = 0.1, and k = 10k0 = 30.  The 
amounts of cellular resources are Z = 105, Y = 105, C0 = 104, and R0 = 104 molecules.  In case 
of a virus encoding a VSR, the corresponding binding constant (ΓC, ΓI or ΓR) takes the value 
of Γ.  The cell volume is assumed ∼ 10−13 L, then 1 nM ∼ 100 molecules. 
Parameter Value Value in the literature 
α 10 h−1 1.7 h−1 for HCV (Dahari et al. 2007) 
µ 10 h−1 10 h−1 for HCV (Dahari et al. 2007) 
β 10 h−1 10 h−1 (Groenenboom & Hogeweg 2008) 
δ 10 h−1 228 h−1 in vitro for E. coli (Sun et al. 2001) 
ρ 1 h−1 ∼5 h−1 (Groenenboom & Hogeweg 2008) 
υ 25 h−1 25 h−1 in vitro for D. melanogaster (Haley & Zamore 2004) 
λ 0.1 h−1 ∼100 M−1h−1 for nucleation (Endres & Zlotnick 2002) 
γ 10 h−1 ∼105 M−1h−1 for elongation (Endres & Zlotnick 2002) 
κS 0.1 h−1 0.5 h−1 (Groenenboom & Hogeweg 2008) 
κI 1 h−1 2 h−1 (Groenenboom & Hogeweg 2008) 
κD 0.01 h−1 0.06 h−1 for HCV (Dahari et al. 2007) 
κP 0.01 h−1 0.01 h−1 (Rana 2007) 
KP 104 molecules 225 nM in vitro for TBSV (Rajendran & Nagy 2006) 
KR 103 molecules 8 nM in vitro for D. melanogaster (Haley & Zamore 2004) 
KZ 104 molecules 260 nM in vitro (Scheper et al. 2002) 
KC 105 molecules 3780 nM (Endres & Zlotnick 2002) 
KD 105 molecules 335 nM in vitro for E. coli (Sun et al. 2001) 
KI 105 molecules ∼1000 molecules (Groenenboom & Hogeweg 2008) 
Γ 103 molecules 10 – 1000 nM in vitro p19, p21 and HC-Pro (Lakatos et al. 2006) 
 
